Jacobio Pharmaceuticals completes HKD 0.46 million on-market buyback, treasury shares rise to 6.76 million

Bulletin Express

May 06

Jacobio Pharmaceuticals Group Co., Ltd. repurchased 72,900 ordinary shares on 06 May 2026 through the Hong Kong Stock Exchange, paying an aggregate HKD 0.46 million at prices between HKD 6.30 and HKD 6.33 per share. The volume-weighted average repurchase price was HKD 6.32 per share.

Following the transaction, the company’s issued share base (excluding treasury shares) fell from 785.07 million to 784.99 million, while treasury shares increased from 6.68 million to 6.76 million. Total issued shares remained unchanged at 791.76 million.

The buyback represented 0.0093 % of the company’s outstanding shares prior to the repurchase. Cumulatively, 3.74 million shares have been repurchased under the mandate approved on 10 June 2025, utilising 0.474 % of the 78.87 million shares authorised for buyback.

In accordance with exchange rules, Jacobio Pharmaceuticals is subject to a moratorium on issuing new shares or disposing of treasury shares until 05 June 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1154203969"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1154203969\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1154203969?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-06 18:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1154203969","market":"us","top_or_hot":-1,"title":"Jacobio Pharmaceuticals completes HKD 0.46 million on-market buyback, treasury shares rise to 6.76 million","media":"Bulletin Express","content":"<p>Jacobio Pharmaceuticals Group Co., Ltd. repurchased 72,900 ordinary shares on 06 May 2026 through the Hong Kong Stock Exchange, paying an aggregate HKD 0.46 million at prices between HKD 6.30 and HKD 6.33 per share. The volume-weighted average repurchase price was HKD 6.32 per share.</p>\n<p>Following the transaction, the company’s issued share base (excluding treasury shares) fell from 785.07 million to 784.99 million, while treasury shares increased from 6.68 million to 6.76 million. Total issued shares remained unchanged at 791.76 million.</p>\n<p>The buyback represented 0.0093 % of the company’s outstanding shares prior to the repurchase. Cumulatively, 3.74 million shares have been repurchased under the mandate approved on 10 June 2025, utilising 0.474 % of the 78.87 million shares authorised for buyback.</p>\n<p>In accordance with exchange rules, Jacobio Pharmaceuticals is subject to a moratorium on issuing new shares or disposing of treasury shares until 05 June 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jacobio Pharmaceuticals completes HKD 0.46 million on-market buyback, treasury shares rise to 6.76 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJacobio Pharmaceuticals completes HKD 0.46 million on-market buyback, treasury shares rise to 6.76 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-06 18:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Jacobio Pharmaceuticals Group Co., Ltd. repurchased 72,900 ordinary shares on 06 May 2026 through the Hong Kong Stock Exchange, paying an aggregate HKD 0.46 million at prices between HKD 6.30 and HKD 6.33 per share. The volume-weighted average repurchase price was HKD 6.32 per share.</p>\n<p>Following the transaction, the company’s issued share base (excluding treasury shares) fell from 785.07 million to 784.99 million, while treasury shares increased from 6.68 million to 6.76 million. Total issued shares remained unchanged at 791.76 million.</p>\n<p>The buyback represented 0.0093 % of the company’s outstanding shares prior to the repurchase. Cumulatively, 3.74 million shares have been repurchased under the mandate approved on 10 June 2025, utilising 0.474 % of the 78.87 million shares authorised for buyback.</p>\n<p>In accordance with exchange rules, Jacobio Pharmaceuticals is subject to a moratorium on issuing new shares or disposing of treasury shares until 05 June 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01167","symbol_name":"加科思-B","start_time":0,"source_url":"","article_id":"1154203969","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1154203969","pubTimestamp":1778064212,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Jacobio Pharmaceuticals Group Co., Ltd. repurchased 72,900 ordinary shares on 06 May 2026 through the Hong Kong Stock Exchange, paying an aggregate HKD 0.46 million at prices between HKD 6.30 and HKD...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01167":"加科思-B"},"translate_title":"雅可比奥制药完成46万港元场内回购库存股升至676万股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01167":1},"content_text":"Jacobio Pharmaceuticals Group Co., Ltd. repurchased 72,900 ordinary shares on 06 May 2026 through the Hong Kong Stock Exchange, paying an aggregate HKD 0.46 million at prices between HKD 6.30 and HKD 6.33 per share. The volume-weighted average repurchase price was HKD 6.32 per share.\nFollowing the transaction, the company’s issued share base (excluding treasury shares) fell from 785.07 million to 784.99 million, while treasury shares increased from 6.68 million to 6.76 million. Total issued shares remained unchanged at 791.76 million.\nThe buyback represented 0.0093 % of the company’s outstanding shares prior to the repurchase. Cumulatively, 3.74 million shares have been repurchased under the mandate approved on 10 June 2025, utilising 0.474 % of the 78.87 million shares authorised for buyback.\nIn accordance with exchange rules, Jacobio Pharmaceuticals is subject to a moratorium on issuing new shares or disposing of treasury shares until 05 June 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}